Related Experiment Video

Updated: Mar 24, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects

Federica Mori1, Maria Ferraiuolo1,2, Raffaela Santoro1

  • 1Molecular Chemoprevention Unit, Molecular Medicine Area, Regina Elena National Cancer Institute, 00144 Rome, Italy.

Oncotarget
|March 12, 2016
PubMed

Insights

Melatonin sustains its tumor suppressor effects long-term by downregulating miR-24, a microRNA targeting DNA repair genes. This inhibition reduces cancer cell proliferation and migration, improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melatonin exhibits short-term tumor suppressor activity via the p38-p53 pathway.
  • The long-term mechanisms of melatonin's anti-cancer effects remain unclear.

Purpose of the Study:

  • To investigate the long-term molecular mechanisms of melatonin's tumor suppressor activity.
  • To explore the role of microRNA-24 (miR-24) in mediating melatonin's sustained effects.

Main Methods:

  • Analysis of miR-24 targeting of p38, p53, PML, and H2AX.
  • Assessment of melatonin's effect on miR-24 levels and downstream gene regulation.
  • Investigation of hnRNP A1's role in miRNA processing.
  • Correlation analysis of miR-24 levels with patient survival data.

Main Results:

  • Long-term melatonin treatment downregulates miR-24 post-transcriptionally.
  • Melatonin inhibits cell proliferation and migration by reducing miR-24 levels.
  • hnRNP A1, downregulated by melatonin, is implicated in miR-24 regulation.
  • miR-24 is upregulated in colon, breast, and head and neck cancers, correlating with poorer survival.

Conclusions:

  • Melatonin exerts sustained tumor suppressor effects by downregulating miR-24.
  • miR-24 is a key mediator of melatonin's long-term anti-cancer activity.
  • Targeting miR-24 represents a potential therapeutic strategy for specific cancers.
Keywords:
PMLRNA-SeqmelatoninmiR-24p53

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
773
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K